Análise comparativa da glicose hipertônica a 75% e do polidocanol no tratamento de microvasos em membros inferiores

This study compared the efficacy and safety of 75% hypertonic glucose and polidocanol-containing formulations for treating lower-limb microvessels. A descriptive and comparative literature review with a qualitative approach was conducted, focusing on three clinical trials: Bertanha et al. (2017), Bertanha et al. (2021), and Fonseca et al. (2023). Vessel reduction, pain, adverse events, number of sessions, and patient satisfaction were examined when reported. In the Bertanha trials, formulations containing 0.2% polidocanol in 70% glucose showed greater vessel reduction than 75% glucose alone. In the Fonseca trial, in which both groups also received Nd:YAG laser treatment, conventional photographic assessments showed no significant between-group differences. Available evidence did not support definitive conclusions regarding the number of sessions or patient satisfaction. Findings should be interpreted in light of vessel type, formulation, treatment protocol, and follow-up period. Individualized treatment decisions and clinical safety remain essential.

Authors

Publication Details

Journal
Revista fisio&terapia.
Published
2026-11-17
DOI
https://doi.org/10.69849/zrd5jw66
Primary Topic
Diagnosis and Treatment of Venous Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Análise comparativa da glicose hipertônica a 75% e do polidocanol no tratamento de microvasos em membros inferiores

Nicole Lopes, Mariana Moreira
Revista fisio&terapia.
Diagnosis and Treatment of Venous Diseases
article

Análise comparativa da glicose hipertônica a 75% e do polidocanol no tratamento de microvasos em membros inferiores

Nicole Lopes, Mariana Moreira
article en

Abstract

This study compared the efficacy and safety of 75% hypertonic glucose and polidocanol-containing formulations for treating lower-limb microvessels. A descriptive and comparative literature review with a qualitative approach was conducted, focusing on three clinical trials: Bertanha et al. (2017), Bertanha et al. (2021), and Fonseca et al. (2023). Vessel reduction, pain, adverse events, number of sessions, and patient satisfaction were examined when reported. In the Bertanha trials, formulations containing 0.2% polidocanol in 70% glucose showed greater vessel reduction than 75% glucose alone. In the Fonseca trial, in which both groups also received Nd:YAG laser treatment, conventional photographic assessments showed no significant between-group differences. Available evidence did not support definitive conclusions regarding the number of sessions or patient satisfaction. Findings should be interpreted in light of vessel type, formulation, treatment protocol, and follow-up period. Individualized treatment decisions and clinical safety remain essential.

Revista fisio&terapia.Vol. 30(164)
Good health and well-being
Diagnosis and Treatment of Venous Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon